Covidien Ltd.Tyco Healthcare Product Pipeline Analysis
| Publication Date | May 2008 |
|---|---|
| Publisher | Global Markets Direct |
| Product Type | Report |
| Pages | 52 |
| ISBN Number | not applicable |
| Product Code | GMD04862 |
Summary
This report is an insightful source for data, analysis and strategic insights into a Covidien Ltd.Tyco Healthcare's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.
Scope
- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.
Reason to buy
- A single source to fulfill competitor information relating to products in development.
- Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
- Access clinical trial information to map trial results and plan targeted marketing activities.
- Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
- Identification of potential investment opportunities.
- Build up knowledge base for potential distribution and marketing partners.
- Helps avoid patent infringement.
- Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.
Content
- 1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
- 2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
- 2.4 Industry Outlook - Cardiovascular Devices
- 2.5 Industry Outlook - Anesthesia and Respiratory Devices
- 2.6 Industry Outlook - Hospital Supplies
- 2.7 Industry Outlook - In Vitro Diagnostics
- 2.8 SWOT Snapshot
- 3 Covidien Ltd./Tyco Healthcare Pipeline Products
- 3.1 Covidien Ltd./Tyco Healthcare Product Pipeline Analysis
- 3.1.1 Covidien Ltd./Tyco Healthcare Pipeline Products By Equipment Type
- 3.1.2 Covidien Ltd./Tyco Healthcare Pipeline Products By Development Stage
- 3.1.3 Covidien Ltd./Tyco Healthcare Pipeline Products By Therapy Area
- 3.1.4 Covidien Ltd./Tyco Healthcare Pipeline Products By News Summary
- 3.2 PleuraSeal Lung Sealant System
- 3.2.1 Product Description
- 3.2.2 Product Status
- 3.2.3 Product Milestone
- 3.3 Sandman Intro CPAP Device
- 3.3.1 Product Description
- 3.3.2 Product Status
- 3.3.3 Product Milestone
- 3.4 Contrast Delivery System
- 3.4.1 Product Description
- 3.4.2 Product Status
- 3.4.3 Product Milestone
- 3.1 Covidien Ltd./Tyco Healthcare Product Pipeline Analysis
- 4 Business Description
- 4.1 Business Overview
- 4.2 Imaging Solutions
- 4.2.1 Overview
- 4.2.2 Financials
- 4.2.3 Capital Expenditure
- 4.2.4 Market View
- 4.2.5 Key Strategies
- 4.3 Medical Devices
- 4.3.1 Overview
- 4.3.2 Financials
- 4.3.3 Capital Expenditure
- 4.3.4 Market View
- 4.3.5 Key Strategies
- 4.4 Medical Supplies
- 4.4.1 Overview
- 4.4.2 Financials
- 4.4.3 Capital Expenditure
- 4.4.4 Market View
- 4.4.5 Key Strategies
- 4.5 Pharmaceutical Products
- 4.5.1 Overview
- 4.5.2 Financials
- 4.5.3 Capital Expenditure
- 4.5.4 Market View
- 4.5.5 Key Strategies
- 4.6 Retail Products
- 4.6.1 Overview
- 4.6.2 Financials
- 4.6.3 Capital Expenditure
- 4.6.4 Market View
- 4.6.5 Key Strategies
- 4.7 Major Products and Services
- 4.7.1 Overview
- 5 History
- 6 Competitors
- 7 Key Employees
- 8 Key Employee Biographies
- 9 Company Statement
- 10 Locations And Subsidiaries
- 10.1 Head Office
- 10.2 Other Locations & Subsidiaries
- 11 Financial Deals Landscape
- 11.1 Acquisition
- 11.1.1 Covidien Acquires Tissue Science Laboratories
- 11.1.2 Covidien Acquires Scandius Biomedical
- 11.2 Debt Offerings
- 11.2.1 Covidien International Finance Completes Private Placement Of $2,750 Million
- 11.3 Partnership
- 11.3.1 Covidien Signs An Agreement With Allergan
- 11.3.2 Covidien And BioSynthema Enter Into Licensing Agreement
- 11.1 Acquisition
- 12 Recent Developments
- 12.1 Strategy and Business Planning
- 12.1.1 Oct 04, 2007: Covidien And NewSouth Innovations Collaborate To Develop Novel Imaging Agent
- 12.2 Financial Announcements
- 12.2.1 May 06, 2008: Covidien Declares Q2 Fiscal 2008 Results
- 12.2.2 Apr 09, 2008: Covidien To Declare Q2 2008 Results
- 12.2.3 Mar 28, 2008: Covidien Spends $760,000 Lobbying Federal Government In 2007
- 12.2.4 Mar 18, 2008: Covidien Declares Quarterly Dividend
- 12.2.5 Feb 07, 2008: Covidien Declares Q1 Fiscal 2008 Results
- 12.2.6 Jan 15, 2008: Covidien Declares Quarterly Dividend
- 12.2.7 Jan 10, 2008: Covidien To Declare Q1 Fiscal 2008 Results
- 12.2.8 Dec 06, 2007: Covidien Reports Q4 Fiscal 2007 Results
- 12.2.9 Sep 28, 2007: Covidien Declares Quarterly Dividend
- 12.2.10 Aug 09, 2007: Covidien Declares Q3 Fiscal 2007 Results
- 12.3 Other Significant Developments
- 12.3.1 Feb 21, 2008: Covidien Gests Favorable Decision In Patent Litigation Case
- 12.1 Strategy and Business Planning
- 13 Appendix
- 13.1 Methodology
- 13.1.1 Coverage
- 13.1.2 Secondary Research
- 13.1.3 Primary Research
- 13.1.4 Expert Panel Validation
- 13.2 Contact Us
- 13.3 About Global Markets Direct
- 13.4 Disclaimer
- 13.1 Methodology
- List of Tables
- Table 1: Covidien Ltd./Tyco Healthcare,Key Facts, 2007
- Table 2: Covidien Ltd./Tyco Healthcare Pipeline Products by Equipment Type
- Table 3: Covidien Ltd./Tyco Healthcare Pipeline Products By Development Stage
- Table 4: Covidien Ltd./Tyco Healthcare Pipeline Products By Therapy Area
- Table 5: Covidien Ltd./Tyco Healthcare Pipeline Products By News Summaries
- Table 6: Covidien Ltd./Tyco Healthcare, Key Employees, 2007
- Table 7: Covidien Ltd./Tyco Healthcare, Other Locations
- Table 8: Covidien Ltd./Tyco Healthcare, Subsidiaries
- List of Figures
- Figure 1: Covidien Ltd./Tyco Healthcare Pipeline Products By Equipment Type
- Figure 2: Covidien Ltd./Tyco Healthcare Pipeline Products By Equipment Type
- Figure 3: Global Markets Direct Methodology
About this Product
Delivery Details
PDF:Delivered by email usually within 24 to 48 UK business hours.
Product features / use
| Scope | Expert Insight/Opinion | ![]() |
| Features | Primary Research Data | ![]() |
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories
















